全文获取类型
收费全文 | 3129篇 |
免费 | 259篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 82篇 |
妇产科学 | 36篇 |
基础医学 | 182篇 |
口腔科学 | 136篇 |
临床医学 | 399篇 |
内科学 | 482篇 |
皮肤病学 | 54篇 |
神经病学 | 281篇 |
特种医学 | 66篇 |
外科学 | 222篇 |
综合类 | 567篇 |
预防医学 | 191篇 |
眼科学 | 47篇 |
药学 | 150篇 |
6篇 | |
中国医学 | 444篇 |
肿瘤学 | 68篇 |
出版年
2024年 | 8篇 |
2023年 | 59篇 |
2022年 | 107篇 |
2021年 | 159篇 |
2020年 | 146篇 |
2019年 | 137篇 |
2018年 | 152篇 |
2017年 | 118篇 |
2016年 | 100篇 |
2015年 | 113篇 |
2014年 | 178篇 |
2013年 | 207篇 |
2012年 | 176篇 |
2011年 | 181篇 |
2010年 | 202篇 |
2009年 | 155篇 |
2008年 | 160篇 |
2007年 | 167篇 |
2006年 | 127篇 |
2005年 | 99篇 |
2004年 | 84篇 |
2003年 | 70篇 |
2002年 | 73篇 |
2001年 | 49篇 |
2000年 | 48篇 |
1999年 | 31篇 |
1998年 | 19篇 |
1997年 | 23篇 |
1996年 | 15篇 |
1995年 | 30篇 |
1994年 | 21篇 |
1993年 | 28篇 |
1992年 | 18篇 |
1991年 | 14篇 |
1990年 | 12篇 |
1989年 | 13篇 |
1988年 | 19篇 |
1987年 | 9篇 |
1986年 | 12篇 |
1985年 | 13篇 |
1984年 | 13篇 |
1983年 | 16篇 |
1982年 | 10篇 |
1981年 | 9篇 |
1980年 | 9篇 |
1979年 | 7篇 |
1978年 | 4篇 |
1977年 | 6篇 |
1975年 | 3篇 |
1974年 | 4篇 |
排序方式: 共有3436条查询结果,搜索用时 0 毫秒
1.
Hepatitis C is a major public health problem worldwide. This disease is caused by the hepatitis C virus, which is characterised by its genetic diversity. The infection is usually asymptomatic. However, between 60% and 80% of HCV-infected individuals will progress to chronic hepatitis, 20% to liver cirrhosis in the medium-to long-term and, each year, between 1% and 4% of these patients with cirrhosis will develop hepatocellular carcinoma (HCC). A Spanish consensus document has recently been drafted to diagnose hepatitis C in a single step, consisting of active investigation (antibodies and viremia) in a single sample, which according to the experts, would reduce the time to access treatment and avoid tracking losses. To definitively change the hepatitis C treatment paradigm, direct-acting antiviral drugs (DAAs) have been approved, whose development has been based on achieving cure rates close to 100% regardless of the genotype of the virus, ie, pangenotypes, with good tolerance and bioavailability. These drugs have constituted a real therapeutic revolution. Supplement information: This article is part of a supplement entitled «SEIMC External Quality Control Programme. Year 2016», which is sponsored by Roche, Vircell Microbiologists, Abbott Molecular and Francisco Soria Melguizo, S.A.© 2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosasy Microbiología Clínica. All rights reserved. 相似文献
2.
D. J. Lederer S. M. Arcasoy R. G. Barr J. S. Wilt E. Bagiella F. D'Ovidio J. R. Sonett S. M. Kawut 《American journal of transplantation》2006,6(10):2436-2442
We previously reported poorer survival among non-Hispanic blacks and Hispanics with idiopathic pulmonary fibrosis (IPF) compared to non-Hispanic whites at our center. In the current study, we hypothesized that these disparities would exist in a nationwide cohort of wait-listed patients with IPF. We performed a retrospective cohort study of 2635 patients with IPF listed for lung transplantation between 1995 and 2003 at 94 transplant centers in the United States. The age-adjusted mortality rate was higher among non-Hispanic blacks [hazard ratio (HR) = 1.24, 95% confidence interval (CI) 1.06-1.45, p = 0.009] and Hispanics (HR = 1.29, 95% CI 1.06-1.56, p = 0.01) compared to non-Hispanic whites. These findings persisted after adjustment for transplantation, medical comorbidities and socioeconomic status. Worse lung function at the time of listing appeared to explain some of these differences (HR for non-Hispanic blacks after adjustment for forced vital capacity percent predicted = 1.16, 95% CI 0.98-1.36, p = 0.09; HR for Hispanics = 1.21, 95% CI 0.99-1.48, p = 0.056). In summary, black and Hispanic patients with IPF have worse survival than whites after listing for lung transplant. 相似文献
3.
4.
5.
芪黄益气汤煎剂治疗慢性前列腺炎的研究 总被引:1,自引:0,他引:1
李惟民 《现代中西医结合杂志》2007,16(14):1897-1899
目的探讨芪黄益气汤煎剂治疗慢性前列腺炎(CP)临床疗效。方法CP患者84例分为芪黄组42例予芪黄益气汤煎剂治疗,清化组42例予清热化瘀煎剂治疗。观察2组CP患者的前列腺液卵磷脂小体、白细胞数、pH值及临床症状的改善情况。结果临床观察芪黄组疗效优于清化组,有显著性差异(P<0.01)。结论以具有益气功效的中药组成的芪黄益气汤煎剂是治疗CP的有效方剂。 相似文献
6.
急性中风中脏腑证型与垂体-肾上腺轴激素关系的研究 总被引:6,自引:0,他引:6
目的 :探讨急性中风中脏腑证型与垂体—肾上腺轴激素的促肾上腺皮质激素 (ACTH)、皮质醇 (CS)的关系。方法 :对 78例中脏腑患者进行辨证分型 ,同时利用放射免疫分析 (RIA)法测定血中 ACTH、CS含量 ,按证型分为四组 ,对比不同证型间 ACTH、CS的水平 ,并与健康人组 (60例 )作对照。结果 :ACTH、CS含量水平比较 :1四种证型的 ACTH、CS均比正常健康人组高 (P <0 .0 0 1 ) ;2四种证型间比较有明显差异 (P<0 .0 1 ) ,从高到低为 :痰热内闭心窍证 >风火上扰清窍证 >痰湿蒙塞心神证 >元气败脱、心神散乱证。结论 :ACTH、CS含量水平可作为判别中脏腑不同证型间的微观指标 相似文献
7.
8.
乳腺癌新辅助化疗后动态增强MRI表现与病理反应性相关性研究 总被引:3,自引:0,他引:3
目的探讨乳腺癌新辅助化疗后动态增强MRI(DCE—MRI)表现的形态学和时间信号强度曲线(TIC)类型与病理学反应性的关系。方法45例乳腺癌患者经新辅助化疗结束后行乳腺DCE—MR检查及手术治疗。应用AW4.2图像工作站观察残余肿瘤强化的形态和TIC类型(共3型)。由病理科医师对乳腺癌化疗后手术标本的病理反应性进行评估,分为1~5级,5级为病理完全缓解,4级和5级为组织学显著反应。分析病理反应性级别与DCE—MRI残余强化的TIC类型、形态的关系,统计方法采用精确概率法。结果45例中病理反应性5级7例,4级16例,3级16例,1和2级共6例。20例I型曲线中组织学显著反应者占70.0%(14/20),而6例Ⅲ型曲线均为组织学反应不显著者。TIC类型在不同的病理反应级别分布差异有统计学意义(P=0.001)。组织学显著反应且有残余强化者共18例,其中非肿块性强化11例。残余强化的肿块(非肿块)形态表现在不同病理反应性分级中分布差异有统计学意义(P=0.012)。结论乳腺癌新辅助化疗后DCE—MRI的形态及血液动力学表现特点与化疗后病理反应性相关。非肿块性强化和I型TIC与组织学显著反应有关。 相似文献
9.
P. Bertram K. -H. Treutner G. Winkeltau H. -J. Booß G. Staatz Prof. Dr. V. Schumpelick 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》1993,378(4):249-254
Zusammenfassung Die Pneumatosis cystoides intestinii (PCI), das Auftreten submuköser oder subseröser, gasgefüllter Zysten in der Wand des Gastrointestinaltrakts, tritt als seltene Erkrankung ohne eindeutige Geschlechtspräferenz vorwiegend in der 3. bis 5. Lebensdekade auf. Atiopathogenetisch werden unterschiedliche Faktoren diskutiert, am wahrscheinlichsten ist eine bakterielle Ursache (Clostridium perfringens) in Verbindung mit einer minimalen Unterbrechung der Mukosaintegrität. Eine pathognomonische Symptomatik gibt es nicht, das klinische Bild reicht von asymptomatischen Zufallsbefunden bis zur Hämatochezie. Die Diagnose wird durch den Nachweis der Gaseinschlüsse mittels Abdomenübersichtsaufnahme und Kolonkontrasteinlauf gestellt. Als Behandlungsmethoden für symptomatische Patienten stehen Sauerstofftherapie, Antibiotikagabe (Metronidazol) und in schweren Fällen die Resektion des betroffenen Darmabschnitts zur Verfügung.
Pneumatosis cystoides intestinalis (PCI), a condition involving submucosal or subserosal gas-containing cysts of the wall of the gastrointestinal tract, is a rare entity. It is mostly diagnosed between the third and fifth decades of life without a clear sexual predominance. Different aetiopathogenetic factors are under discussion, the most probable being a bacteriologic cause (Clostridium perfringens) in combination with minimal leaks in mucosal barrier. There are no pathognomonic symptoms; the clinical picture ranges from incidental findings to haematochezia. Diagnosis is based on plain abdominal film and X-ray following barium enema. Methods of treatment in symptomatic cases are oxygen and antibiotic (metronidazole) therapies and, in severe cases, resection of the diseased part of the intestine.相似文献
10.
Donna White Suzanne Moore Stephen Waring Karon Cook Eugene Lai 《Movement disorders》2007,22(7):915-923
To better understand the impact of incident Parkinson's disease (PD) on the Veteran's Health Administration (VHA) and to develop methods applicable to future epidemiological research, we performed a medical record review study at a tertiary referral VHA medical center. Searching the local data base, we identified 782 veterans with diagnostic codes for PD or secondary parkinsonism (SP) between 1998 and 2000. Based on structured medical record review, a movement disorders specialist confirmed diagnoses for incident parkinsonism cases. Among the 782, 191 incident parkinsonism cases were identified (100 PD, 75 SP, and 16 Parkinson's Plus). Incident PD cases were older at diagnosis (74.5 vs. 70.4 yr; P < 0.05) and more likely to be white (81% vs. 62; P < 0.07) than incident SP cases. Diagnostic codes were insufficient to distinguish between incident PD and SP (positive predictive value, 57% and 39%, respectively), and VHA sources failed to identify 21% of confirmed deaths among the incident PD cohort by November 2004. Although the large number of incident cases identified suggests PD is an important cause of disability among elderly VHA users, observed limitations of VHA sources for identifying incident PD cases and determining their vital status should be considered when designing future studies. 相似文献